CAR T cells as novel therapeutic strategy for multiple sclerosis and other neuroimmune disorders
Sara Samadzadeh(University of Southern Denmark), ECF Young Investigators/Fellows Initiative, Sanja Gluščević(University of Montenegro), Natalia Szejko(University of Calgary), Wan Ying Tan(University of Connecticut), Y. Hamadah(University of Connecticut), Vinícius Boldrini(Universidade Estadual de Campinas (UNICAMP)), Xavier Montalban(Universitat de Vic - Universitat Central de Catalunya), Vito A. G. Ricigliano(Inserm)
Cited by 4
Related Papers
A “Candidate-Interactome” Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis
|PLoS ONE|2013|511
Choroid Plexus Enlargement in Inflammatory Multiple Sclerosis: 3.0-T MRI and Translocator Protein PET Evaluation
|Radiology|2021|196
Twin studies in multiple sclerosis: A meta-estimation of heritability and environmentality
|Multiple Sclerosis Journal|2015|75